Evidence map›Paper›PMID 29978754›Full record

ArticleLeukemia & lymphoma2019

Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.

Alankrita Taneja, Jade Jones, Stefania Pittaluga, Irina Maric, Mohammed Farooqui, Inhye E Ahn, Adrian Wiestner, Clare Sun

Abstract readCase ReportsLetter
In one paragraph

Article in Leukemia & lymphoma, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alankrita Tanejaa Hematology Branch , National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda , MD , USA.ORCID 0000-0002-7231-2623
Jade Jonesb Division of Cancer Medicine , MD Anderson Cancer Center , Houston , TX , USA.
Stefania Pittalugac Laboratory of Pathology , National Cancer Institute, National Institutes of Health , Bethesda , MD , USA.
Irina Maricd Department of Laboratory Medicine , Clinical Center National Institutes of Health , Bethesda , MD , USA.
Mohammed Farooquia Hematology Branch , National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda , MD , USA.
Inhye E Ahna Hematology Branch , National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda , MD , USA.
Adrian Wiestnera Hematology Branch , National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda , MD , USA.
Clare Suna Hematology Branch , National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda , MD , USA.ORCID 0000-0001-8498-4729

Funding

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapyZIAHL002346 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI WIESTNER, ADRIAN U · 2009 to 2025
$29.8M
Bone Marrow Histopathological Changes in Neoplastic and Non-Neoplastic DiseasesZIACL090027 · CLC · CLINICAL CENTER · PI MARIC, IRINA · 2010 to 2025
$0k
Intramural NIH HHS Z99 CA999999Intramural NIH HHS Z99 CL999999Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Transformation, NeoplasticAgammaglobulinaemia Tyrosine KinaseAntineoplastic AgentsBiomarkersBiopsyHodgkin DiseaseHumansLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedMultimodal ImagingProtein Kinase InhibitorsAgammaglobulinaemia Tyrosine KinaseAntineoplastic AgentsBiomarkersBTK protein, humanProtein Kinase Inhibitors

Identifiers

PMID29978754
PMCPMC6600815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.